COMMUNIQUÉS West-GlobeNewswire

Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021
09/08/2019
LAKE FOREST, Ill., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) (“Assertio”) today announced it has entered into separate, privately negotiated exchange agreements (the “Exchange [...]
NovaBay Pharmaceuticals Announces Pricing of $2.7 Million Private Placement of Preferred Stock and Accompanying Warrants to Purchase Common Stock
09/08/2019
EMERYVILLE, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, today [...]
NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering
09/08/2019
EMERYVILLE, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, today [...]
Predictive Technology Group Announces Launch of PGxPLUS+™ Pharmacogenomic Test and Reaches Clinical Study Enrollment Milestone
09/08/2019
Enrollment reaches 350 patients for IRB-approved study focused on chronic pain SALT LAKE CITY, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics [...]
PROJECT HOPE CALLS FOR CONTINUED FOREIGN AID AMIDST GLOBAL CRISES THREATENING LIVES AND LIVELIHOODS
09/08/2019
90 humanitarian and development organizations urge the U.S. administration to reconsider freezing funds for U.S. foreign assistance programs Millwood, Virginia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- “Millions of children, [...]
Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
09/08/2019
Reports Positive Preliminary Top-Line Safety Data for APVO210 Phase 1 Single Ascending Dose (SAD) Clinical Study Advances APVO210 into Phase 1 Multiple Ascending Dose (MAD) Study Commences Dosing in Cohort 4 of APVO436 [...]
B. Braun Awarded Best Research Article of 2018 by BI&T
09/08/2019
First-of-its-kind Study Reveals Impact of Infusion Pump Alarms on Patients and Clinicians BETHLEHEM, Pa., Aug. 09, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced that it has been selected by the Association [...]
Two clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded
09/08/2019
Biohit Oyj Stock Exchange Release August 9th 2019 at 15.30 pm local time (EET) In 2014, Biohit Oyj initiated two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule [...]
Akari Therapeutics announces new data demonstrating synergistic benefits of nomacopan’s bifunctional C5 and LTB4 inhibitory activity in pemphigoid disease
09/08/2019
New data from bullous pemphigoid (BP) patients and pemphigoid disease (PD) models generated by Dr. Christian Sadik’s group at University of Lubeck, Germany published in the August 2019 edition of JCI Insight (see link [...]
Cocrystal Pharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
09/08/2019
– Company continues to drive clinical and research programs forward to achieve multiple value-driving milestones– – Business development initiative underway with active discussions ongoing to secure additional strategic [...]
Tyme Technologies to Present at BTIG Biotechnology Conference on August 12th, 2019
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the [...]
Galectin Therapeutics Reports Q2 2019 Financial Results and Provides Business Update
09/08/2019
NORCROSS, Ga., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business [...]
VBI Vaccines Announces Second Quarter 2019 Financial Results and Provides Corporate Update
09/08/2019
Positive top-line data from PROTECT Phase 3 for Sci-B-Vac ® , trivalent hepatitis B vaccine, announced June 2019 – top-line data from second Phase 3 study, CONSTANT, expected around year-end 2019 ASCO presentation [...]
Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference
09/08/2019
LAVAL, Québec, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction
09/08/2019
Nasdaq Ticker Symbol “NLTX” to be effective Monday, August 12, 2019 SEATTLE, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated [...]
Gemphire Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
09/08/2019
LIVONIA, Mich., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a [...]
Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan
09/08/2019
Company Initiates Search for New Chief Executive Officer MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and [...]
Progenics Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update
09/08/2019
Recorded First Revenues for AZEDRA ® ; CMS Grants New Technology Add-On Payment of Up to $98,150 per Therapeutic Dose for Inpatient Use of AZEDRA Enrollment Completed Ahead of Schedule in Phase 3 CONDOR Trial of PyL TM [...]
TG Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
09/08/2019
Conference call to be held today, Friday, August 9, 2019 at 8:30 AM ET NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ended [...]

Pages